A detailed history of Mgo One Seven LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Mgo One Seven LLC holds 14,958 shares of TEVA stock, worth $267,299. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,958
Previous 11,940 25.28%
Holding current value
$267,299
Previous $168,000 44.64%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$12.78 - $17.4 $38,570 - $52,513
3,018 Added 25.28%
14,958 $243,000
Q1 2024

May 14, 2024

BUY
$10.67 - $14.43 $127,399 - $172,294
11,940 New
11,940 $168,000
Q3 2023

Nov 03, 2023

BUY
$7.48 - $10.7 $164 - $235
22 Added 0.17%
13,326 $135,000
Q2 2023

Aug 11, 2023

BUY
$7.2 - $9.47 $280 - $369
39 Added 0.29%
13,304 $100,000
Q1 2023

May 08, 2023

SELL
$8.36 - $11.37 $2,031 - $2,762
-243 Reduced 1.8%
13,265 $117,000
Q4 2022

Jan 25, 2023

SELL
$7.95 - $9.48 $4,642 - $5,536
-584 Reduced 4.14%
13,508 $0
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $583 - $1,015
85 Added 0.61%
14,092 $113,000
Q2 2022

Aug 10, 2022

SELL
$7.38 - $10.4 $1,483 - $2,090
-201 Reduced 1.41%
14,007 $105,000
Q1 2022

May 13, 2022

BUY
$7.33 - $9.39 $104,144 - $133,413
14,208 New
14,208 $133,000
Q1 2019

Apr 09, 2019

SELL
$15.58 - $20.01 $21,625 - $27,773
-1,388 Closed
0 $0
Q4 2018

Jan 24, 2019

BUY
$14.59 - $23.84 $20,250 - $33,089
1,388 New
1,388 $21,000
Q3 2018

Oct 09, 2018

SELL
$21.06 - $25.65 $11,688 - $14,235
-555 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$16.68 - $22.07 $400 - $529
-24 Reduced 4.15%
555 $9,000
Q4 2017

Feb 16, 2018

BUY
$11.23 - $19.1 $6,502 - $11,058
579
579 $11,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.8B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Mgo One Seven LLC Portfolio

Follow Mgo One Seven LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mgo One Seven LLC with notifications on news.